News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
5665
Sources here
18
Companies here
31
Search results Stored financial headlines

Active search

5665 matching headlines

Ticker or company: ESOMain company stories
Clear
Latest

seekingalpha.com Earnings

Bulls and bears hash it out on MGM Resorts

[Las Vegas Skyline] LPETTET/iStock via Getty Images MGM Resorts International (MGM [https://seekingalpha.com/symbol/MGM]) continues to trade lower than where it stood before the casino giant issued its second quarter earnings report. Analysts have issued differing post-earnings assessments of MGM (MGM [https://seekingalpha.com/symbol/MGM]). Argus reiterated a Buy rating on MGM Resorts (MGM [https://seekingalpha.com/symbol/MGM]) as it pointed to a Macau visitation recovery …

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Forrestania appoints MEGA for Tycho open-pit operations

Forrestania Resources has selected MEGA Resources to undertake the open-pit mining development at the Tycho Gold Project in Australia. The contract, which covers stage one mining operations at Tycho, has an estimated value of around A$27m and is expected to run for roughly seven …

FRS main company
Sharemaestro market context Price below Trend Line 52 weeks +113.9% · Next-week setup negative 35.4% FRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Laramide Resources secures Swedish uranium exploration licences

Laramide Resources has acquired exploration licences in two Swedish uranium regions, Hotagen and Arjeplog-Arvidsjaur. The move gives the company, which is active in uranium development and exploration in the US and Australia, a presence in one of Europe's most prospective areas for uranium resources. …

LAM main company
Sharemaestro market context Price below Trend Line 52 weeks +22.0% · Next-week setup negative 43.6% LAM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q2 Earnings Roundup: Monarch (NASDAQ:MCRI) And The Rest Of The Consumer Discretionary - Casino Operator Segment

Q2 Earnings Roundup: Monarch (NASDAQ:MCRI) And The Rest Of The Consumer Discretionary - Casino Operator Segment Wrapping up Q2 earnings, we look at the numbers and key takeaways for the consumer discretionary - casino operator stocks, including Monarch (NASDAQ:MCRI) and its peers. The Consumer …

MCRI main company
Sharemaestro market context Trend signal active 52 weeks +19.6% MCRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

350 Patients Have Been Treated—Mesoblast’s Pain Data Come Next

Mesoblast (MESO) has completed patient treatment in its pivotal Phase 3 trial (MSB-DR004) for chronic low back pain associated with degenerative disc disease, treating 350 patients. The trial evaluates rexlemestrocel-L and targets a primary endpoint of durable pain reduction at 12 months. Top-line results …

MESO main company
Sharemaestro market context Price above Trend Line 52 weeks -1.4% MESO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mesoblast completes patient treatment in phase 3 back pain trial By Investing.com

Mesoblast Limited has completed patient treatment in its phase 3 trial for rexlemestrocel-L, aimed at chronic low back pain associated with degenerative disc disease. The trial enrolled 350 patients and seeks to confirm durable pain reduction as its primary endpoint, with top-line results anticipated …

MESO main company
Sharemaestro market context Price above Trend Line 52 weeks -1.4% MESO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mesoblast Achieves Major Milestone in Pivotal Phase 3 Chronic Low Back Pain Trial

Mesoblast Limited has completed patient treatment in its pivotal Phase 3 trial for chronic low back pain, with 350 patients receiving rexlemestrocel-L or a sham injection. This milestone moves the company closer to potential market entry for its allogeneic cellular medicine, which has RMAT …

MESO main company
Sharemaestro market context Price above Trend Line 52 weeks -1.4% MESO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Franklin Resources, Inc. will Change its Name to Franklin Templeton, Inc

Franklin Resources, Inc. announced that it will change its corporate name to Franklin Templeton, Inc., effective August 17, 2026. This change is highlighted in an article published on August 16, 2026, at 8:35 PM EDT. The company specializes in investment fund management, with significant …

BEN main company
Sharemaestro market context Trend signal active 52 weeks +39.0% BEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

Mesoblast Limited NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has completed patient treatment in the MSB-DR004 pivotal randomized controlled Phase 3 trial of rexlemestrocel-L for chronic …

MSB main company
Sharemaestro market context Price above Trend Line 52 weeks -7.1% MSB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Small Cap Watch: D3 Energy, Astral Resources, Surefire and Dalaroo advance company programs

Small Cap Watch: D3 Energy, Astral Resources, Surefire and Dalaroo advance company programs Proactive uses images sourced from Shutterstock The S&P/ASX Small Ordinaries (ASX: XSO) finished Friday at 3,517.10 points, down 24.30 points or 0.69% for the session. Over the past five trading days, …

AAR main company
Sharemaestro market context Price below Trend Line 52 weeks -9.1% · Next-week setup negative 36.0% AAR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Melco Resorts & Entertainment Limited Just Missed Earnings - But Analysts Have Updated Their Models

Melco Resorts & Entertainment Limited (NASDAQ:MLCO) recently reported disappointing Q2 results, missing revenue and EPS expectations. Following this, analysts have slightly downgraded their EPS forecasts for 2026, though revenue estimates remain largely unchanged. Despite the earnings miss and slower projected revenue growth compared to …

MLCO main company
Sharemaestro market context Price below Trend Line 52 weeks -39.0% MLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context